X-linked agammaglobulinemia (XLA) results from a failure of B lymphoid development. We have previously examined pre-B cell hybrids from three patients with XLA and found them to be limited to production of a novel germ line transcript of the Ig H chain locus composed of a leader sequence (LS) spliced to the constant region of g chain (CM) as mRNA and polypeptide. These transcripts result from transcriptional activation of the germ line heavy chain locus from an LS exon upstream of the embryonic JHlocus. Germ line LS-CM transcripts are produced by pre-B cells from normal bone marrow and fetal liver, indicating that they are products of normal pre-B cell development, as part of the process of transcriptional activation to provide access for the recombinase. Bone marrow from three patients with XLA has been examined directly by polymerase chain reaction amplification to determine whether the exclusive pro- 
Introduction
X-linked agammaglobulinemia (XLA)' is a congenital antibody deficiency disease linked to Xq2 (1, 2). The major phenotype of XLA is associated with arrest in B lymphoid develop-ment at the stage of pre-B cells (3) . This arrest is generally accepted to be causative ofthe disease. Rare B lymphocytes are found in peripheral blood of some patients, constituting < 1% of the B cell population of a normal individual (4) . The failure of B lymphoid development is subject to X chromosome inactivation in carriers, with consequent clonal failure of development of B lymphocytes from precursors in which the XLA bearing chromosome is active (5, 6) . Normal development ofB lymphocytes in which the disease-bearing X chromosome is inactivated indicates that the disease is recessive and intrinsic to the B lymphoid precursors.
The primary event in pre-B cell development is recombination ofimmunoglobulin variable diversityjoining (V(D)J) gene elements to generate a functional variable region (7) . Variable regions are assembled by selection and recombination from the sets of V, D, and J gene elements in an ordered sequence (8, 9) . First a D gene element is recombined with a JH gene element, and then a VH is recombined with the DJH intermediate (10) .
Formation of a mature VHDJHCA is followed by light chain recombination. V(D)J recombination is catalyzed by a single recombinase that acts in the sequential steps of Ig recombination and in the recombination of T cell antigen receptors (1 1). The recombinase is proposed to be directed in its cell lineage specificity and in its sequential steps of recombination by control of its access (12) . Transcriptional activation of the recombining gene elements is associated with access for the recombinase. Transcription of unrearranged VH gene elements and DJH intermediate structures occurs in close correlation with VH to DJH recombination (13, 14) . Germ line transcriptional activation of the JHlocus precedes D to JH recombination (14, 15) , and activation of the JKlocus precedes VK to JK recombination (16) . Similar transcriptional activation occurs in recombination of the elements of the T cell antigen receptor (17) .
We have previously proposed that the failure of pre-B cell development in XLA results from a primary failure ofIg V(D)J recombination (18) . This proposal resulted from the exclusive production ofgerm line transcripts ofthe heavy chain locus by pre-B cell hybrids from XLA bone marrow. Germ line transcripts, composed of a leader sequence (LS) spliced to the constant region of u chain (Cu), were produced by a limited number of pre-B cell hybrids derived from normal fetal liver, indicating that LS-Cu was a product of normal pre-B cell development. LS-CAu is the product ofan LS exon that is [14] [15] [16] kb upstream of the JH locus (15) . Transcription from the LS exon provides transcriptional activation of the JH locus.
I have now used the polymerase chain reaction (PCR) to determine whether the exclusive production ofgerm line transcripts by XLA pre-B cell hybrids is representative of XLA bone marrow pre-B cells. I find that LS-Cgu is a product of normal bone marrow, and is the predominant product of XLA bone marrow. Some Dg transcripts from the DJH intermediate step of recombination are present in XLA bone marrow. Mature VHDJHCA products were not identified in bone marrow from three XLA patients, using a variety of 5' primers for amplification. These results indicate that V(D)J recombination is a rate-limiting step in XLA bone marrow pre-B cells, associated with the failure of pre-B cell development.
Methods
Samples of bone marrow were obtained by biopsy of iliac crest. Bone marrow was aspirated into preservative-free heparin. Informed consent was obtained from each individual biopsied, following procedures approved by the Committee on Human Subjects at Children's Hospital of Boston. Mononuclear cells were separated by buoyant density centrifugation on Ficoll-paque (Pharmacia Fine Chemicals, Piscataway, NJ), and adherent cells were removed by incubation in plastic (petri shaped) culture dishes overnight at 37°. Resulting cells were counted, pelleted by centrifugation, the supernatant removed, and stored as cell pellets at -80°. Normal fetal liver RNA was kindly provided by Dr. Eric Hoffman (University of Pittsburgh, PA).
RNA was extracted from cell pellets by lysis in guanidine-HCl as described by Chirgwin et al. ( 19) , followed by differential ethanol precipitation, and phenol and chloroform extraction. cDNA was synthesized with cloned Moloney murine leukemia virus reverse transcriptase (Bethesda Research Laboratories, Gaithersburg, MD) using random hexamer primers. 5 pl of reaction was removed, mixed with 10 1ACi of 32P dCTP, and incubated in parallel. Radioactivity incorporated was used to determine the amount of cDNA synthesized.
Genomic DNA for Southern blotting was digested with HindIll to completion, electrophoresed, transferred to Gene Screen Plus (New England Nuclear, Boston, MA) and probed with the 2-kb Sau3AI fragment ofthe human genomic JH locus clone described by Ravetch et al. (20) .
PCR were performed as described previously (15) . The PCR blots were probed with the 1.6-kb CM cDNA insert from the plasmid puHM2 (18) .
Markers were either X DNA digested with HindIII or phiX 174 digested with HinfL.
Results
The primers used for these experiments, their positions on mature and precursor mRNAs (cDNAs), and the anticipated amplification products of these primers are shown in Fig. 1 conserved in these variants of ub9. The sequence differences from ub9 result in two amino acid substitutions in 2-33, and in three substitutions for 5-4. One and two, respectively, of these substitutions are conservative for polar charge. All ofthe substitutions retain sequences that are within the variation observed for known heavy chain leader sequences, suggesting that these two additional sequences function as leader sequences for translation ofCu into polypeptide. The observed sequence variation in upstream leader sequences likely represents polymorphism in the LS exon rather than PCR artifact for two reasons. First, the 2-33 sequence has been found on seven additional clones derived from this and from another amplification of the same cDNA, which would Ib9 GGACTCACC ATG GAG TTT GGG CTG ACC TGG GTT TTC CTC GTT GCT CTT TTA A GA Cp require the same substitutions to be made early in two separate reactions. The 5-4 sequence was found in two clones from one reaction. It may represent a second allele of LS exon in this individual. Second, no variation has been found in the 246 nucleotides of CQ determined from these clones. This suggests that there is a high degree of polymorphism in the LS exons of different individuals. The bands migrating between 600 and 700 bp have not been sequenced, but hybridization of these bands with probes for CIu JH, and VH 1 and VH3 seems sufficient to confirm that they represent mature VDJCu. The several bands between 600 and 700 bp suggest that the LSP primer hybridizes upstream ofmultiple VH gene elements, and that the variation in size results from the variability in N region insertion of the VH to D and D to JH joins. 5' flanking sequences that would be primed by LSP have been identified from the published sequences ofgene elements from the VH 1, 3, and 4 gene families. Of published VH gene sequences, 27 extend far enough upstream to be able to determine whether the LSP primer would cross-hybridize. Of those 27 VH gene elements, 9 have sufficient identity to amplify with the LSP primer in the PCR reaction.
Amplification of cDNA from normal peripheral blood lymphocytes yielded only the 600-to 700-bp bands characteristic of mature VDJC, (Fig. 2) . Absence of the 360-bp LS-C'R band from circulating lymphocytes is consistent with the germ line transcription of LS-Cu from the heavy chain locus in precursor cells resident in bone marrow. Normal fetal liver from a 22-wk abortus amplified with LSP/CQ primers was used as a counterpart to normal bone marrow that would not be enriched for mature VHDJHCIR sequences from plasma cells.
Amplification of the fetal liver cDNA with LSP/Cu primers yielded 360-and 600-to 700-bp bands that were comparable to those found with normal bone marrow (data not shown). Fig. 1 , the products of these primers should migrate between 380 and 420 bp. Amplification of fetal liver and normal bone marrow yielded a collection of bands in this size range, identified by ethidium staining and by Southern hybridization (Fig.  6) . cDNA from two patients yielded bands in the 380-to 420-bp band by ethidium staining in one experiment (Fig. 6, (1 1, 25) . T cell-mediated immunity is normal in XLA (1), further indicating that the recombinase is not affected. It seems most likely that a normal recombinase acts in both T and B cells of XLA, but the rate of recombination is greatly reduced in B cells. Leakiness resulting in a limited amount of V(D)J recombination is consistent with observations in other genetic diseases. Thalassemia resulting from mutation in an RNA splice site is associated with production ofsome normal globin (see reference 26, for example), and severe combined immunodeficiency in mice resulting from aberrant recombinase activity is associated with some normal V(D)J recombination (27) .
Mature ,t chains of the rare XLA B lymphocytes were not detected by PCR amplification. This may result from rapid entry ofany cell that does create a productive VDJ into peripheral circulation. Conley (4) identified B lymphocytes in peripheral blood of XLA patients at a frequency between 1:100 and 1:1,000 of normal. A previous study of XLA bone marrow examined sufficient numbers of cells to have identified B cells at this frequency, but did not identify any (3). There is variability between patients in the degree of leakiness in generating B cells. We do not know the degree ofleakiness in the patients we studied. However, reconstruction experiments of PCR amplifications with the primers we used indicate that we could detect mature ji chain with as little as 0.1 ng of normal fetal liver cDNA, corresponding to a 1,000-fold reduction in numbers of B cells in XLA bone marrow compared to normal.
The recombinase is proposed to be directed in its sequential steps by regulation of access (10) . Access for recombination is closely associated with transcriptional activation of the recombining gene elements (13, 14) . LS-Cli germ line transcripts pre- (14) .
We have proposed that XLA results from a primary defect in Ig V(D)J recombination as a primary cause for arrest in the transition from pre-B cell to B lymphocyte (18) . 
